Key result
Surgery plus radiochemotherapy achieves over 3 years of survival in a primary cardiac angiosarcoma case.
Case Report (n=1)
No
This case report demonstrates a survival of over three years in a patient with primary cardiac angiosarcoma treated with surgical resection and radiochemotherapy.
Answers are grounded in this paper and cite their sources.
Supports multimodal therapy as a potential option in select young patients with cardiac angiosarcoma; leaves open the need for prospective data.
A healthy 18-year-old girl was referred to our hospital for further evaluations of cardiac angiosarcoma. Transthoracic echocardiography showed an immobile 4.6 cm×3.7 cm cardiac mass. The mass was occupying right atrial chamber and partially, invading into annulus of tricuspid valve on transesophageal echocardiography. At surgery, the mass was seen to be protruding from right atrial appendage and adhering to right side of pericardium. The histological findings were consistent with cardiac angiosarcoma and immunological staining was positive for CD34 and CD31. Afterward, although she received radiochemotherapy, she died of metastasis of cardiac angiosarcoma more than three years after surgical resection. J. Med. Invest. 64: 181-183, February, 2017.
No takes yet. Share an insight, caveat, or question.
Fukunaga et al. (2017) conducted a case report in Primary cardiac angiosarcoma (n=1). Surgical resection and radiochemotherapy was evaluated on Survival. Surgical resection combined with radiochemotherapy achieved a survival of more than three years in an 18-year-old female with primary cardiac angiosarcoma before she died of liver metastasis.
Synapse has enriched 10 related papers. Consider them for comparative context: